Agenda
Friday, May 2, 2025
PLENARY SESSIONS | EXHIBITS
Time
Session
7:00 am EDT
Check-In
Breakfast, Visit Exhibit Hall and View Posters
8:00 am EDT
Welcome Remarks
Alison W. Loren, MD, MSCE | Penn Medicine
Joseph W. St. Geme, III, MD | Children's Hospital of Philadelphia
PLENARY SESSION 4: The Next Frontier in CAR T Autoimmune Disease
Moderator: David L. Porter, MD | Penn Medicine | Symposium Co-Chair
Time
Session
8:15 am EDT
Rationale for B Cell Directed Cell Therapy in Autoimmune Disease
Peter A. Merkel, MD, MPH | Penn Medicine
8:35 am EDT
CAR T Cells in Autoimmune Diseases: Novel insights from growing experience
Fabian Mueller, MD | University Hospital of Erlangen
8:55 am EDT
Suppress or Destroy: Two approaches to engineer T cells for the treatment of autoimmune disease
James L. Riley, PhD | Penn Medicine
9:15 am EDT
Discussion
PLENARY SESSION 5: Pioneering Novel Frontiers in Stem Cell Transplantation and Engineering
Moderator: Alexis A. Thompson, MD, MPH | Children's Hospital of Philadelphia | Symposium Co-Chair
Time
Session
9:25 am EDT
Engineering Immunity: αβ T-Cell Depleted and γδ T-Cell Enhanced Haplo-HSCT for Transplantation and Immunotherapy.
Alice Bertaina, MD, PhD | Stanford University
9:45 am EDT
From Ex Vivo to In Vivo Gene Therapy
Stefano B. Rivella, PhD | Children's Hospital of Philadelphia
10:05 am EDT
Genetically Engineered Hematopoietic Stem Cell Transplantation for Cancer
Saar I. Gill, MD, MBBS, PhD, FRACP | Penn Medicine
10:25 am EDT
Discussion
BREAK
Time
Session
10:35 am EDT
VISIT EXHIBITS
PLENARY SESSION 6: Location, Location, Location: CAR T in Solid Tumors
Moderator: Carl H. June, MD | Penn Medicine | Symposium Co-Chair
Time
Session
10:55 am EDT
Engineered NK Cells for Cancer Immunotherapy: From bench to bedside
Katy Rezvani, MD, PhD | MD Anderson Cancer Center
11:10 am EDT
GFRa4 as a CAR-T Cell Target for the Treatment of Medullary Thyroid Cancer
Donald L. Siegel, PhD, MD | Penn Medicine
11:25 am EDT
Balancing Toxicity and Potency to Optimize the Therapeutic Window in CAR T Cell Therapy for Advanced Prostate Cancer
Joseph A. Fraietta, PhD | Penn Medicine
11:40 am EDT
Discussion
PLENARY SESSION 7: Celling Advanced Therapies: Navigating the Translation from Academia to Industry
Bruce L. Levine, PhD | Penn Medicine | Symposium Co-Chair
Time
Session
11:50 am EDT
Reprogramming CAR T-Cell Therapy for Lymphomas: Innovations in targeting and efficacy
Marco Ruella, MD | Penn Medicine
12:10 pm EDT
Towards a Platform for In Vivo Corrective Editing of Ultra-Rare and N-of-1 Metabolic Disorders
Kiran Musunuru, MD, PhD, MPH, ML, MRA | Penn Medicine
12:30 pm EDT
12:50 pm EDT
Discussion
1:00 pm EDT
CLOSING REMARKS
Cellicon Valley Co-Chairs
1:05 pm EDT
ADJOURN
Lunch to Go